BRIEF—Servier Australia and BioCurate collaborate

BioCurate has struck an agreement with the Australian subsidiary of privately-held French pharma company Servier to share commercial and scientific expertise with the aim of accelerating the discovery of new therapeutics and drugs.

Servier Australia and BioCurate will collaborate under the terms of a memorandum of understanding (MoU), whereby they will work together, both directly and via participation in BioCurate’s Industry and Scientific Advisory Committee, in providing advice and assessing new therapeutic candidates arising from BioCurate’s academic partners.

The signing of this MoU provides further endorsement from industry of BioCurate’s collaborative approach and its capability in improving the quality of early stage research for a successful translation into therapeutic solutions for the benefit of patients, the Australian firm claims.